These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 15243059)

  • 1. Studies on the involvement of the exopolysaccharide produced by cystic fibrosis-associated isolates of the Burkholderia cepacia complex in biofilm formation and in persistence of respiratory infections.
    Cunha MV; Sousa SA; Leitão JH; Moreira LM; Videira PA; Sá-Correia I
    J Clin Microbiol; 2004 Jul; 42(7):3052-8. PubMed ID: 15243059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence.
    Drevinek P; Mahenthiralingam E
    Clin Microbiol Infect; 2010 Jul; 16(7):821-30. PubMed ID: 20880411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exopolysaccharides produced by clinical strains belonging to the Burkholderia cepacia complex.
    Herasimenka Y; Cescutti P; Impallomeni G; Campana S; Taccetti G; Ravenni N; Zanetti F; Rizzo R
    J Cyst Fibros; 2007 Apr; 6(2):145-52. PubMed ID: 16860003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The OmpR Regulator of Burkholderia multivorans Controls Mucoid-to-Nonmucoid Transition and Other Cell Envelope Properties Associated with Persistence in the Cystic Fibrosis Lung.
    Silva IN; Pessoa FD; Ramires MJ; Santos MR; Becker JD; Cooper VS; Moreira LM
    J Bacteriol; 2018 Sep; 200(17):. PubMed ID: 29914989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the role of matrix components in protection of Burkholderia cepacia complex biofilms against tobramycin.
    Messiaen AS; Nelis H; Coenye T
    J Cyst Fibros; 2014 Jan; 13(1):56-62. PubMed ID: 23932109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virulence of Burkholderia cepacia complex strains in gp91phox-/- mice.
    Sousa SA; Ulrich M; Bragonzi A; Burke M; Worlitzsch D; Leitão JH; Meisner C; Eberl L; Sá-Correia I; Döring G
    Cell Microbiol; 2007 Dec; 9(12):2817-25. PubMed ID: 17627623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasion and biofilm formation of Burkholderia dolosa is comparable with Burkholderia cenocepacia and Burkholderia multivorans.
    Caraher E; Duff C; Mullen T; Mc Keon S; Murphy P; Callaghan M; McClean S
    J Cyst Fibros; 2007 Jan; 6(1):49-56. PubMed ID: 16781896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burkholderia cenocepacia, B. multivorans, B. ambifaria and B. vietnamiensis isolates from cystic fibrosis patients have different profiles of exoenzyme production.
    Carvalho AP; Ventura GM; Pereira CB; Leão RS; Folescu TW; Higa L; Teixeira LM; Plotkowski MC; Merquior VL; Albano RM; Marques EA
    APMIS; 2007 Apr; 115(4):311-8. PubMed ID: 17504297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression alterations.
    Coutinho CP; Dos Santos SC; Madeira A; Mira NP; Moreira AS; Sá-Correia I
    Front Cell Infect Microbiol; 2011; 1():12. PubMed ID: 22919578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection.
    Martina P; Feliziani S; Juan C; Bettiol M; Gatti B; Yantorno O; Smania AM; Oliver A; Bosch A
    Int J Med Microbiol; 2014 Nov; 304(8):1182-91. PubMed ID: 25217078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of recombinant human lactoferrin on growth and the antibiotic susceptibility of the cystic fibrosis pathogen Burkholderia cepacia complex when cultured planktonically or as biofilms.
    Caraher EM; Gumulapurapu K; Taggart CC; Murphy P; McClean S; Callaghan M
    J Antimicrob Chemother; 2007 Sep; 60(3):546-54. PubMed ID: 17595284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interspecies biofilms of Pseudomonas aeruginosa and Burkholderia cepacia.
    Tomlin KL; Coll OP; Ceri H
    Can J Microbiol; 2001 Oct; 47(10):949-54. PubMed ID: 11718549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulator LdhR and d-Lactate Dehydrogenase LdhA of Burkholderia multivorans Play Roles in Carbon Overflow and in Planktonic Cellular Aggregate Formation.
    Silva IN; Ramires MJ; Azevedo LA; Guerreiro AR; Tavares AC; Becker JD; Moreira LM
    Appl Environ Microbiol; 2017 Oct; 83(19):. PubMed ID: 28733286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center.
    Petrucca A; Cipriani P; Valenti P; Santapaola D; Cimmino C; Scoarughi GL; Santino I; Stefani S; Sessa R; Nicoletti M
    Res Microbiol; 2003 Sep; 154(7):491-8. PubMed ID: 14499935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the role of extracellular polysaccharides in Burkholderia adaptation to different environments.
    Ferreira AS; Silva IN; Oliveira VH; Cunha R; Moreira LM
    Front Cell Infect Microbiol; 2011; 1():16. PubMed ID: 22919582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical course of Burkholderia cepacia complex bacteria respiratory infection in cystic fibrosis patients.
    Correia S; Nascimento C; Pereira L; Cunha MV; Sá-Correia I; Barreto C
    Rev Port Pneumol; 2008; 14(1):5-26. PubMed ID: 18265915
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Narayanaswamy VP; Duncan AP; LiPuma JJ; Wiesmann WP; Baker SM; Townsend SM
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910901
    [No Abstract]   [Full Text] [Related]  

  • 18. Mucoid and nonmucoid Burkholderia cepacia complex bacteria in cystic fibrosis infections.
    Zlosnik JE; Costa PS; Brant R; Mori PY; Hird TJ; Fraenkel MC; Wilcox PG; Davidson AG; Speert DP
    Am J Respir Crit Care Med; 2011 Jan; 183(1):67-72. PubMed ID: 20709823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucoid morphotype variation of Burkholderia multivorans during chronic cystic fibrosis lung infection is correlated with changes in metabolism, motility, biofilm formation and virulence.
    Silva IN; Ferreira AS; Becker JD; Zlosnik JEA; Speert DP; He J; Mil-Homens D; Moreira LM
    Microbiology (Reading); 2011 Nov; 157(Pt 11):3124-3137. PubMed ID: 21835880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis.
    Jones AM; Dodd ME; Govan JR; Barcus V; Doherty CJ; Morris J; Webb AK
    Thorax; 2004 Nov; 59(11):948-51. PubMed ID: 15516469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.